INCY News and Press, Incyte Corporation From 04/26/24

2024-04-26 13:45:12 ET Summary Incyte Corporation shares have underperformed lately, but the company has shown solid growth, profitability, and increased net cash position. Diversification from its blockbuster drug Jakafi has been slow, but overall appeal has improved. The com...

2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...

2024-04-23 07:31:43 ET More on Incyte Incyte: A Potential GARP Superstar Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript Incyte Corporation 2023 Q4 - Results - Earnings Call Presentation Incyte and CMS collaborate for povorcitinib in Mainland China...

EP262, a first-in-class oral Mas-related G protein-coupled receptor X2 (MRGPRX2) antagonist with the potential to treat a broad range of inflammatory disorders, has demonstrated proof-of-mechanism in chronic inducible urticaria and is in a Phase 2 study for chronic spontaneous urticaria E...

2024-04-22 16:25:01 ET More on S&P 500 Index: Why AI Stocks Could Go Boom Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Nasdaq, S&P, an...

2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...

2024-04-19 11:56:37 ET The selloff in the S&P 500 over the past couple of weeks has pulled certain stocks into what is considered oversold territory, according to the relative strength index technical indicator.... Read the full article on Seeking Alpha For further details s...

2024-04-12 12:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-07 06:30:00 ET Summary ProfoundBio, a Seattle ADC company with an R&D facility in Suzhou, will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. China Medical System in-licensed povorcitinib, an oral JAK1 inhibitor, from San Franciscoȁ...

2024-04-06 11:54:38 ET A U.S. district court jury has found a former pharmaceutical company executive liable for insider trading allegations brought by the Securities and Exchange Commission (SEC).... Read the full article on Seeking Alpha For further details see: Jury sides...